Cargando…
Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer
BACKGROUND: Colorectal cancer (CRC) remains a major cause of cancer fatalities in developed countries. The risk of death is correlated to the stage of CRC during the primary diagnosis. Early diagnosis is closely associated with enhanced survival rate. We therefore investigated the AP-F13A1 as a pote...
Autores principales: | Peltier, Julien, Roperch, Jean-Pierre, Audebert, Stéphane, Borg, Jean-Paul, Camoin, Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890357/ https://www.ncbi.nlm.nih.gov/pubmed/29657559 http://dx.doi.org/10.1186/s12014-018-9191-3 |
Ejemplares similares
-
Advances of Coagulation Factor XIII
por: Shi, Da-Yu, et al.
Publicado: (2017) -
Use of coagulation factor XIII (F13) gene as an internal control for normalization of genomic DNA’s for HLA typing
por: Neduvat, Anupama Cheleri, et al.
Publicado: (2018) -
Inhibition of Fibrinolysis by Coagulation Factor XIII
por: Rijken, Dingeman C., et al.
Publicado: (2017) -
Coagulation Factor XIII in Cerebral Venous Thrombosis
por: Li, Bojun, et al.
Publicado: (2019) -
The Structure of Blood Coagulation Factor XIII Is Adapted to Oxidation
por: Vasilyeva, Alexandra, et al.
Publicado: (2020)